AnaIltis United StatesWake Forest University

AnaIltis
Ana S. Iltis, PhD. is the Carlson Professor of University Studies, Professor of Philosophy, and Director, Center for Bioethics, Health and Society at Wake Forest University. She holds an appointment in the Department of Social Sciences and Health Policy at Wake Forest School of Medicine. Dr. Iltis is Founding Co-Editor of Narrative Inquiry in Bioethics (Johns Hopkins University Press), Associate Editor of the Journal of Medicine and Philosophy (Oxford University Press), and co-editor of the Annals of Bioethics (Routledge) series. She is a past president of the American Society for Bioethics and Humanities. Iltis’ scholarly focus is primarily on the ethical conduct of human research, including research involving children, first-in-human studies, mental health research, organ transplantation research, and risk in research decision-making. She also works on ethics and policy issues regarding emerging biotechnologies. She is the embedded ethicist in the APOLLO (APOL-1 Long-Term Kidney Transplantation Outcomes) Consortium.
Institution

Day 1 - Sunday April 14, 2024

Time Session
9 a.m.
10:30 a.m.
SK100
Fatiu AbiolaArogundade Chairperson NigeriaObafemi Awolowo University Teaching Hospitals Complex/ National Postgraduate Medical College of Nigeria
FernandaSales Luiz Vianna Chairperson fslvianna@gmail.comBrazilUniversidade Federal do Rio Grande do Sul
OpeyemiOlabisi Chairperson opeyemi.olabisi@duke.eduUnited StatesDuke University School of Medicine
  • Ethical Aspects of Race-based Genetic Testing
    AnaIltis Speaker iltisas@wfu.eduUnited StatesWake Forest University
  • Contribution of ApoL1 Risk Genotype to HIVAN
    SaraladeviNaicker Speaker South AfricaUniversity of the Witwatersrand
  • Contribution of APOL1 Risk Alleles to Kidney Disease in West Africa
    DwomoaAdu Speaker dwoms@blueyonder.co.ukGhanaUniversity of Ghana Medical School
  • Targeting ApoL1: A 12-Year Journey from Genetic Discovery to Phase 2 Trials
    OgoEgbuna Speaker ogo_egbuna@vrtx.comUnited StatesVertex Pharmaceuticals Inc
  • Q and A
Hall C2